Opportunity: Our client had recently received $10M in seed funding and was focused on building out their team in their wet lab in Philadelphia. The or
GTS Scientific ramps headcount for aseptic upstream manufacturing level III specialists for one client, and creates a second shift for another (level II).
Opportunity: Our client, a cell therapy company focused on cancer immunotherapy products, was looking to create a 2nd shift at their manufacturing fac
June 2023 | Issue No. 10 The latest news and updates from GTS Scientific Events Attended: BIO International Stand up for innovation.
Opportunity: A Philadelphia-based precision health company needed to build and grow their CLIA lab personnel to help meet company growth objectives. T
This spotlight focuses on our client, a health and wellness company focused on developing topical delivery products to help address unmet needs in the
Release date: 3/29/23 The Inc. 5000 ranks companies by overall revenue growth over a three-year period. All 5,000 honoree companies are individually p
Please join us for Life Sci Sips! Please join GTS Scientific and Gallagher for March's Life Sci Sips event. This month's event is Wednesday March
Overview: A Boston-based private equity firm focused on healthcare investing had recently acquired a CRO in the Greater Philadelphia area focused on
A Philadelphia area CRO had just been acquired by Private Equity at the beginning of 2022. Their new ownership group put a lot of investment into the